These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35213534)

  • 61. PharmGWAS: a GWAS-based knowledgebase for drug repurposing.
    Kang H; Pan S; Lin S; Wang YY; Yuan N; Jia P
    Nucleic Acids Res; 2024 Jan; 52(D1):D972-D979. PubMed ID: 37831083
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Signatures of cell death and proliferation in perturbation transcriptomics data-from confounding factor to effective prediction.
    Szalai B; Subramanian V; Holland CH; Alföldi R; Puskás LG; Saez-Rodriguez J
    Nucleic Acids Res; 2019 Nov; 47(19):10010-10026. PubMed ID: 31552418
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predicting mechanism of action of novel compounds using compound structure and transcriptomic signature coembedding.
    Jang G; Park S; Lee S; Kim S; Park S; Kang J
    Bioinformatics; 2021 Jul; 37(Suppl_1):i376-i382. PubMed ID: 34252937
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Computational Bipartite Graph-Based Drug Repurposing Method.
    Zheng S; Ma H; Wang J; Li J
    Methods Mol Biol; 2019; 1903():115-127. PubMed ID: 30547439
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A novel drug repurposing approach for non-small cell lung cancer using deep learning.
    Li B; Dai C; Wang L; Deng H; Li Y; Guan Z; Ni H
    PLoS One; 2020; 15(6):e0233112. PubMed ID: 32525938
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An effective multi-task learning framework for drug repurposing based on graph representation learning.
    Ye S; Zhao W; Shen X; Jiang X; He T
    Methods; 2023 Oct; 218():48-56. PubMed ID: 37516260
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
    Fiscon G; Conte F; Farina L; Paci P
    PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prediction of Drug-Target Interaction Using Dual-Network Integrated Logistic Matrix Factorization and Knowledge Graph Embedding.
    Li J; Yang X; Guan Y; Pan Z
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014371
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A heterogeneous network-based method with attentive meta-path extraction for predicting drug-target interactions.
    Wang H; Huang F; Xiong Z; Zhang W
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35641162
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Leveraging Big Data to Transform Drug Discovery.
    Glicksberg BS; Li L; Chen R; Dudley J; Chen B
    Methods Mol Biol; 2019; 1939():91-118. PubMed ID: 30848458
    [TBL] [Abstract][Full Text] [Related]  

  • 71. New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing.
    Zador Z; King AT; Geifman N
    PLoS One; 2018; 13(3):e0194701. PubMed ID: 29558515
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
    Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
    Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
    Karatzas E; Kolios G; Spyrou GM
    Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Breaking the paradigm: Dr Insight empowers signature-free, enhanced drug repurposing.
    Chan J; Wang X; Turner JA; Baldwin NE; Gu J
    Bioinformatics; 2019 Aug; 35(16):2818-2826. PubMed ID: 30624606
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Data-driven drug discovery for drug repurposing].
    Saito R; Yano N; Kojima S; Miyoshi F
    Nihon Yakurigaku Zasshi; 2023; 158(1):10-14. PubMed ID: 36596476
    [TBL] [Abstract][Full Text] [Related]  

  • 76. SumGNN: multi-typed drug interaction prediction via efficient knowledge graph summarization.
    Yu Y; Huang K; Zhang C; Glass LM; Sun J; Xiao C
    Bioinformatics; 2021 Sep; 37(18):2988-2995. PubMed ID: 33769494
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Partner-Specific Drug Repositioning Approach Based on Graph Convolutional Network.
    Sun X; Wang B; Zhang J; Li M
    IEEE J Biomed Health Inform; 2022 Nov; 26(11):5757-5765. PubMed ID: 35921345
    [TBL] [Abstract][Full Text] [Related]  

  • 78. NTD-DR: Nonnegative tensor decomposition for drug repositioning.
    Jamali AA; Tan Y; Kusalik A; Wu FX
    PLoS One; 2022; 17(7):e0270852. PubMed ID: 35862409
    [TBL] [Abstract][Full Text] [Related]  

  • 79. DrSim: Similarity Learning for Transcriptional Phenotypic Drug Discovery.
    Wei Z; Zhu S; Chen X; Zhu C; Duan B; Liu Q
    Genomics Proteomics Bioinformatics; 2022 Oct; 20(5):1028-1036. PubMed ID: 36182102
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Predicting drug-target interactions using restricted Boltzmann machines.
    Wang Y; Zeng J
    Bioinformatics; 2013 Jul; 29(13):i126-34. PubMed ID: 23812976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.